ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer
出版年份 2021 全文链接
标题
ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 15, Pages 3373
出版商
MDPI AG
发表日期
2021-07-29
DOI
10.3390/jcm10153373
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
- (2021) Matteo Calligaris et al. MOLECULES
- ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment
- (2021) Nathalie Théret et al. Cancers
- Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo
- (2020) Hong-Yuan Lu et al. LIFE SCIENCES
- GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17
- (2020) Subbroto Kumar Saha et al. Molecular Therapy-Oncolytics
- Role of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelium Dysfunction
- (2020) Mi Zhou et al. Frontiers in Cell and Developmental Biology
- TGF-β Induced CTGF Expression in Human Lung Epithelial Cells through ERK, ADAM17, RSK1, and C/EBPβ Pathways
- (2020) Shu-Ching Ou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The molecular, cellular and pathophysiological roles of iRhom pseudoproteases
- (2019) Iqbal Dulloo et al. Open Biology
- The metalloprotease ADAM17 in inflammation and cancer
- (2019) Stefan Düsterhöft et al. PATHOLOGY RESEARCH AND PRACTICE
- Functions of ‘A disintegrin and metalloproteases (ADAMs)’ in the mammalian nervous system
- (2019) Hung-En Hsia et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
- (2019) Bin Yang et al. Cell Death & Disease
- A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer
- (2019) Rohan Kar et al. Genes
- Regulation of Fibrotic Processes in the Liver by ADAM Proteases
- (2019) Dirk Schmidt-Arras et al. Cells
- Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments
- (2018) Stefan F Lichtenthaler et al. EMBO JOURNAL
- ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma
- (2018) Yong Li et al. EXPERIMENTAL CELL RESEARCH
- Regulation of profibrotic responses by ADAM17 activation in high glucose requires its C-terminus and FAK
- (2018) Renzhong Li et al. JOURNAL OF CELL SCIENCE
- ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
- (2018) Stefanie Schmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
- (2018) Yingshi Zhang et al. Cell Death & Disease
- Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
- (2017) Marcia L. Moss et al. MEDIATORS OF INFLAMMATION
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
- (2017) Joseph Dosch et al. Oncotarget
- Role of epithelial–mesenchymal transition in proliferative vitreoretinopathy
- (2016) Shigeo Tamiya et al. EXPERIMENTAL EYE RESEARCH
- ADAM17 promotes epithelial-mesenchymal transition via TGF-β/Smad pathway in gastric carcinoma cells
- (2016) Min Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Role of epithelial to mesenchymal transition in hepatocellular carcinoma
- (2016) Gianluigi Giannelli et al. JOURNAL OF HEPATOLOGY
- ADAMs family and relatives in cardiovascular physiology and pathology
- (2016) Pu Zhang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways
- (2016) Jinbing Sun et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method
- (2016) Ganglong Yang et al. MOLECULES
- The role of ADAM17 in tumorigenesis and progression of breast cancer
- (2016) Hongyu Shen et al. TUMOR BIOLOGY
- Phosphatidylserine exposure is required for ADAM17 sheddase function
- (2016) Anselm Sommer et al. Nature Communications
- Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation
- (2016) SungWoo Hong et al. Oncotarget
- Control of ADAM17 activity by regulation of its cellular localisation
- (2016) Inken Lorenzen et al. Scientific Reports
- iRhoms in the brain – a new frontier?
- (2015) Stefan F Lichtenthaler et al. CELL CYCLE
- The Effect of cAMP-PKA Activation on TGF-β1-Induced Profibrotic Signaling
- (2015) Lin Weng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Loss of ADAM17 is associated with severe multiorgan dysfunction
- (2015) Robert H.J. Bandsma et al. HUMAN PATHOLOGY
- Integrin-linked kinase mediates CTGF-induced epithelial to mesenchymal transition in alveolar type II epithelial cells
- (2015) Mitra Shafieian et al. PEDIATRIC RESEARCH
- Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
- (2015) Michael Kreuter et al. Biomed Research International
- MicroRNAs as potential targets for progressive pulmonary fibrosis
- (2015) Subbiah Rajasekaran et al. Frontiers in Pharmacology
- ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-κB-dependent activation of Snail
- (2015) Magdalena A. Cichon et al. Oncotarget
- ADAM17 at the interface between inflammation and autoimmunity
- (2014) Sabrina Lisi et al. IMMUNOLOGY LETTERS
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cell Stress Induces Upregulation of Osteopontin via the ERK Pathway in Type II Alveolar Epithelial Cells
- (2014) Aki Kato et al. PLoS One
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial–mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance
- (2014) Young-Joo Kim et al. TOXICOLOGY
- Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1–7
- (2013) Bruce D. Uhal et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
- (2013) Norihiko Sakai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-α cleavage by ADAM17
- (2013) Ming-Qing Gao et al. CANCER LETTERS
- TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion
- (2013) Orsi Giricz et al. INTERNATIONAL JOURNAL OF CANCER
- Thrombin-Induced CCAAT/Enhancer-Binding Protein Activation and IL-8/CXCL8 Expression via MEKK1, ERK, and p90 Ribosomal S6 Kinase 1 in Lung Epithelial Cells
- (2013) C.-H. Lin et al. JOURNAL OF IMMUNOLOGY
- iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding
- (2013) T. Maretzky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antifibrotic Activity of Sorafenib in Experimental Hepatic Fibrosis: Refinement of Inhibitory Targets, Dosing, and Window of Efficacy In Vivo
- (2012) Feng Hong et al. DIGESTIVE DISEASES AND SCIENCES
- Sjögren’s syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB
- (2012) M Sisto et al. GENES AND IMMUNITY
- New lives for old: evolution of pseudoenzyme function illustrated by iRhoms
- (2012) Colin Adrain et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- ADAM17 Silencing in Mouse Colon Carcinoma Cells: The Effect on Tumoricidal Cytokines and Angiogenesis
- (2012) Sudipta Das et al. PLoS One
- Differential expression of the ADAMs in developing chicken retina
- (2011) Xin Yan et al. DEVELOPMENT GROWTH & DIFFERENTIATION
- The role of ADAM-mediated shedding in vascular biology
- (2011) Daniela Dreymueller et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes
- (2011) Yue-Lei Chen et al. HEPATOLOGY
- Epithelial–mesenchymal transition in chronic liver disease: Fibrogenesis or escape from death?
- (2011) Massimo Pinzani JOURNAL OF HEPATOLOGY
- Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB
- (2011) Sabrina Lisi et al. LABORATORY INVESTIGATION
- ADAM-17 Is Activated by the Mitogenic Protein Kinase ERK in a Model of Kidney Fibrosis
- (2010) L. Gabriel Navar et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- ADAM-17: A Target to Increase Chemotherapeutic Efficacy in Colorectal Cancer?
- (2010) A. M. Lee et al. CLINICAL CANCER RESEARCH
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin–TACE–amphiregulin axis
- (2010) Sabrina Lisi et al. JOURNAL OF AUTOIMMUNITY
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
- (2010) Yan Wang et al. JOURNAL OF HEPATOLOGY
- ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin
- (2010) J Malapeira et al. ONCOGENE
- Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
- (2009) Thomas Amann et al. CANCER SCIENCE
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
- (2009) Boris R. A. Blechacz et al. HEPATOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- ADAM10-Mediated E-Cadherin Release Is Regulated by Proinflammatory Cytokines and Modulates Keratinocyte Cohesion in Eczematous Dermatitis
- (2008) Thorsten Maretzky et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The ADAM metalloproteinases
- (2008) D EDWARDS et al. MOLECULAR ASPECTS OF MEDICINE
- Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas
- (2008) F. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
- The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer
- (2008) Jessica Pruessmeyer et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The “A Disintegrin And Metalloprotease” (ADAM) family of sheddases: Physiological and cellular functions
- (2008) Karina Reiss et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now